BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like Amag Investors Cheer as Biotech Wins Second Drug Approval This Month February 15, 2018 Rumor Mill: Johnson & Johnson, Novartis AG and Takeda are All Making Googly Eyes at This Brazilian Drugmaker April 24, 2017 Illumina Spins Out Forensic Genetics Business Into New Company, August 23, 2017
Rumor Mill: Johnson & Johnson, Novartis AG and Takeda are All Making Googly Eyes at This Brazilian Drugmaker April 24, 2017